About this trial
This study aims to stabilize the patients with bipolar disorder (BD) comorbid with obesity in the stable phase by using temporal interference stimulation (TIS ) intervention. It intends to investigate the changes in key metabolic molecules such as GLP-1 circadian rhythm, and further explore the molecular mechanism of their metabolic disorders.
Eligibility criteria
Qualifiers
Both biological parents are of Han ethnicity;
Age range: 18 to 45 years old, gender not restricted;
Meets the clinical diagnostic criteria for bipolar disorder as stipulated in the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
Body Mass Index (BMI) ≥ 28 kg/m2, or for males, waist circumference ≥ 90 cm and for females, waist circumference ≥ 85 cm;
Disqualifiers
Individuals with other DSM-5 spectrum disorders;
Mental disorders caused by substance abuse (such as alcohol, drugs, etc.), and those with severe physical illnesses;
Those who consumed food or microecological preparations containing probiotics, prebiotics, etc. within one week before enrollment, and had a history of respiratory, urinary, digestive system infections and antibiotic use within one month before enrollment;
Those currently having serious suicidal thoughts or behaviors, or those with severe agitation;
Trial design
Treatments tested in this trial
- Temporal Interference Stimulation
- Sham Temporal Interference Stimulation Arm Description